Alpha lipoic acid for kids on dialysis
Treatments studied
Part of Heart & circulation, Kidney & urinary clinical trials.
This trial tests if alpha lipoic acid, a common supplement, can help reduce stress on the body for children who are on regular hemodialysis. It may offer a way to support their health during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is 18 years old or younger and goes to dialysis regularly.
- Your child can swallow capsules (pills).
- Your child does not have severe heart failure.
- Your child does not have an active inflammatory condition (like a bad infection or autoimmune disease).
- Your child is not already taking supplements that lower oxidative stress or inflammation.
- Your child is not allergic to alpha lipoic acid.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking omega-3 supplements (a type of healthy fat) can help reduce stress on the body and improve nutrition in children who are on regular hemodialysis. If your child fits the age and dialysis requirements and has not taken similar supplements recently, they may be able to join.
This trial tests whether taking alpha lipoic acid (an antioxidant) can protect the kidneys from damage caused by the strong antibiotic colistin. It is for adults with serious infections who are already receiving colistin through an IV.
This study tests whether a supplement called alpha-lipoic acid can help protect your kidneys from damage caused by cisplatin, a common chemotherapy drug. If it works, it could reduce side effects and help you tolerate your cancer treatment better.
This trial tests if a medication can protect the liver during chemotherapy for children and teenagers newly diagnosed with acute lymphoblastic leukemia (ALL). It aims to reduce liver damage caused by treatment.
This trial tests if acupuncture laser therapy can help people on hemodialysis (kidney dialysis). It may offer a gentle, non-invasive way to manage symptoms or improve well-being.
This trial tests whether spironolactone can help treat anemia in children aged 6-18 who are on hemodialysis. It may improve their response to current anemia treatments.
Hear when a new Hemodialysis Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.